| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.885926 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107171302 |
|---|
| 006 | m o d f |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 200417t20202020oncd ob f000 0 eng d |
|---|
| 020 | |a9780660345949|q(part 1) |
|---|
| 020 | |a9780660345956|q(part 2) |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH82-50/1-2020E-PDF |
|---|
| 086 | 1 |aH82-50/2-2020E-PDF |
|---|
| 245 | 00|aBiologics in Canada. |
|---|
| 264 | 1|aOttawa, ON : |bPatented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, |c2020. |
|---|
| 264 | 4|c©2020 |
|---|
| 300 | |a1 online resource (2 volumes) : |bgraphs |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |a"May 2020." |
|---|
| 500 | |aCover title. |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 500 | |a"Chartbook National Prescription Drug Utilization Information System (NPDUIS)"--Cover. |
|---|
| 500 | |aIssued also in French under title: Les médicaments biologiques au Canada. |
|---|
| 504 | |aIncludes bibliographical references (page 31). |
|---|
| 505 | 0 |aPart 1: Market trends, 2018 -- Part 2: Biosimilar savings, 2018. |
|---|
| 520 | |a"This analysis examines the market dynamics of biologics in Canada and compares Canadian and international trends in sales, pricing, and biosimilar uptake. Part 2 uses recent Canadian and international trends to expose the current and future cost savings that could be realized through increasing the uptake and/or lowering the prices of biosimilars in Canada"--Introduction, page 5. |
|---|
| 650 | 0|aBiologicals|zCanada. |
|---|
| 650 | 0|aBiologicals|xPrices|zCanada. |
|---|
| 650 | 0|aPharmaceutical industry|zCanada. |
|---|
| 710 | 1 |aCanada. |bPatented Medicine Prices Review Board, |eissuing body. |
|---|
| 775 | 08|tLes médicaments biologiques au Canada.|w(CaOODSP)9.885927 |
|---|
| 856 | 40|qPDF|s1.23 MB|uhttps://publications.gc.ca/collections/collection_2020/cepmb-pmprb/H82-50-1-2020-eng.pdf|zPart 1 |
|---|
| 856 | 40|qPDF|s1.06 MB|uhttps://publications.gc.ca/collections/collection_2020/cepmb-pmprb/H82-50-2-2020-eng.pdf|zPart 2 |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/patented-medicine-prices-review/services/reports-studies/biologics-part1-market-trends.html|zPart 1 |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/patented-medicine-prices-review/services/reports-studies/biologics-part2-biosimilar-savings2018.html|zPart 2 |
|---|